本文選題：轉(zhuǎn)基因作物 + 實質(zhì)等同��； 參考：《自然辯證法研究》2017年08期

【摘要】：隨美國轉(zhuǎn)基因標識法案通過,實質(zhì)等同作為轉(zhuǎn)基因作物評價準則已被基本否定。該原則存在實驗不足、忽視過程、線性邏輯、缺乏歷時等方面的科學方法缺陷。同時,它還蘊涵技術(shù)紅利價值偏好的非科學缺陷。這會造成人體健康生態(tài)環(huán)境與市場接受度等安全層面,或基于科學假設(shè)、或基于利益推測的不確定性結(jié)果�；诖�,應(yīng)從科學風險舉證性、評價操作合理性及利害取舍正當性層面來建構(gòu)轉(zhuǎn)基因作物評價原則體系。
[Abstract]:With the passage of the US GMO labeling Act, substantive equivalence has been basically denied as a criterion for GM crop evaluation. There are some defects in this principle, such as lack of experiment, neglect of process, linear logic and lack of diachronic scientific methods. At the same time, it also contains the unscientific defect of the value preference of technical dividend. This will result in the safety aspects of human health, ecological environment and market acceptance, either based on scientific assumptions or uncertainty based on profit speculation. Therefore, the evaluation principle system of transgenic crops should be constructed from the aspects of scientific risk proof, the rationality of evaluation operation and the legitimacy of selection of interests.
【作者單位】： 北京航空航天大學人文與社會科學學院;
【基金】：北京市軟科學項目(Z151100002615031)
【分類號】：S188
，

本文編號：1914953